Abstract
No public abstract is available from the verified source records.
Ladislav ValkoviCˇ, Stefan Neubauer, Oliver J. Rider
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Phosphorus NMR studies on perfused heart
10.1016/0006-291x(77)91653-9 · 1977
NMR Spectroscopy of the human heart
2009
Metabolic imaging of the human heart: clinical application of magnetic resonance spectroscopy
10.1136/heartjnl-2012-302546 · 2014
MRS: a noninvasive window into cardiac metabolism
10.1002/nbm.3320 · 2015
Clinical cardiac magnetic resonance spectroscopy
10.1016/j.pcad.2011.08.002 · 2011
Magnetic resonance spectroscopy in myocardial disease
10.1016/j.jcmg.2008.08.005 · 2009
Unresolved referenced work
2002
Unresolved referenced work
1995
Unresolved referenced work
2007
Unresolved referenced work
2000
Terminology and concepts for the characterization of in vivo MR spectroscopy methods and MR spectra: background and experts’ consensus recommendations
2020
Improved method for accurate and efficient quantification of MRS data with use of prior knowledge
10.1006/jmre.1997.1244 · 1997
OXSA: An open-source magnetic resonance spectroscopy analysis toolbox in MATLAB
10.1371/journal.pone.0185356 · 2017
Estimation of metabolite concentrations from localized in-Vivo Proton NMR-Spectra
10.1002/mrm.1910300604 · 1993
Unresolved referenced work
2008
Quantification of human high-energy phosphate metabolite concentrations at 3 T with partial volume and sensitivity corrections
10.1002/nbm.2961 · 2013
Feasibility of absolute quantification for (31) P MRS at 7 T
10.1002/mrm.27729 · 2019
Phosphorus nuclear magnetic resonance spectroscopy of cardiac and skeletal muscles
1982
Transport of energy in muscle: the phosphorylcreatine shuttle
10.1126/science.6450446 · 1981
Fluxes through cytosolic and mitochondrial creatine kinase, measured by P-31 NMR
10.1023/a:1006847605088 · 1997
The creatine-phosphocreatine system: there’s more than one song in its repertoire
10.1113/jphysiol.2001.013478 · 2001
Cardiac magnetic resonance spectroscopy
2003
In vivo assessment of free magnesium concentration in human brain by P-31 MRS. A new calibration curve based on a mathematical algorithm
10.1002/(sici)1099-1492(199602)9:1<24::aid-nbm392>3.0.co;2-b · 1996
In vivo P-31-MRS assessment of cytosolic [Mg2+] in the human skeletal muscle in different metabolic conditions
10.1016/s0730-725x(00)00132-6 · 2000
Relation between work and phosphate metabolite in the in vivo paced mammalian heart
10.1126/science.3704638 · 1986
Transmural bioenergetic responses of normal myocardium to high workstates
1995
Roles of the creatine kinase system and myoglobin in maintaining energetic state in the working heart
10.1186/1752-0509-3-22 · 2009
Systems level regulation of cardiac energy fluxes via metabolic cycles: role of creatine, phosphotransfer pathways, and AMPK signaling
10.1007/978-3-642-38505-6_11 · 2014
On the theoretical limits of detecting cyclic changes in cardiac high-energy phosphates and creatine kinase reaction kinetics using in vivo P-31 MRS
10.1002/nbm.3302 · 2015
Temporal relation between energy-metabolism and myocardial-function during ischemia and reperfusion
1987
Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction
10.1172/jci117756 · 1995
Triple repetition time saturation transfer (TRiST) P-31 spectroscopy for measuring human creatine kinase reaction kinetics
10.1002/mrm.22347 · 2010
Unresolved referenced work
Kept as external metadata until matched
In-vivo(31)P-MRS of skeletal muscle and liver: a way for non-invasive assessment of their metabolism
10.1016/j.ab.2017.01.018 · 2017
High resolution proton NMR studies of perfused rat hearts
10.1016/0014-5793(84)80835-2 · 1984
1H NMR measurement of triacylglycerol accumulation in the post-ischemic canine heart after transient increase of plasma lipids
10.1006/jmcc.1996.9997 · 1997
Noninvasive localized MR quantification of creatine kinase metabolites in normal and infarcted canine myocardium
10.1148/radiology.219.2.r01ma39411 · 2001
Reduced (1)H-NMR visibility of creatine in isolated rat hearts
10.1002/(sici)1522-2594(200004)43:4<497::aid-mrm2>3.0.co;2-m · 2000
Non-invasive magnetic-resonance detection of creatine depletion in non-viable infarcted myocardium
10.1016/s0140-6736(97)06402-7 · 1998
Water-suppression cycling 3-T cardiac (1) H-MRS detects altered creatine and choline in patients with aortic or mitral stenosis
10.1002/nbm.4513 · 2021
Contribution of various substrates to total citric acid cycle flux and anaplerosis as determined by 13C isotopomer analysis and O2 consumption in the heart
10.1007/bf01759778 · doi-reference
Hyperpolarized metabolic MR imaging of acute myocardial changes and recovery after ischemia-reperfusion in a small-animal model
10.1148/radiol.2015151332 · doi-reference
Metabolic imaging of acute and chronic infarction in the perfused rat heart using hyperpolarised [1‐13C] pyruvate
10.1002/nbm.2972 · doi-reference
DIABETES PDH FED In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance
10.1073/pnas.0805953105 · doi-reference
Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy
10.1136/heartjnl-2022-322271 · doi-reference
Effects of the novel long-acting GLP-1 Agonist, albiglutide, on cardiac function, cardiac metabolism, and exercise capacity in patients with chronic heart failure and reduced ejection fraction
10.1016/j.jchf.2016.01.008 · doi-reference
TrimetaziDine as a Performance-enhancING drug in heart failure with preserved ejection fraction (DoPING-HFpEF): rationale and design of a placebo-controlled cross-over intervention study
10.1007/s12471-020-01407-z · doi-reference
Assessment of cardiac energy metabolism, function, and physiology in patients with heart failure taking empagliflozin: the randomized, controlled EMPA-VISION trial
10.1161/circulationaha.122.062021 · doi-reference
Clinical features of myocardial triglyceride in different types of cardiomyopathy assessed by proton magnetic resonance spectroscopy: comparison with myocardial creatine
10.1016/j.cardfail.2010.05.006 · doi-reference
Usefulness of 1H MR spectroscopy in the evaluation of myocardial metabolism in patients with dilated idiopathic cardiomyopathy: pilot study
10.1016/s1076-6332(03)00104-1 · doi-reference
Left ventricular function and myocardial triglyceride content on 3 T Cardiac MR predict major cardiovascular adverse events and readmission in patients hospitalized with acute heart failure
10.3390/jcm9010169 · doi-reference
Myocardial triglyceride content at 3 T cardiovascular magnetic resonance and left ventricular systolic function: a cross-sectional study in patients hospitalized with acute heart failure
10.1186/s12968-016-0228-3 · doi-reference
Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure
10.1093/eurheartj/ehi816 · doi-reference
Retained metabolic flexibility of the failing human heart
10.1161/circulationaha.122.062166 · doi-reference
Improvement in cardiac energetics by perhexiline in heart failure due to dilated cardiomyopathy
10.1016/j.jchf.2014.09.009 · doi-reference
Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved
10.1172/jci57426 · doi-reference
The interplay between metabolic alterations, diastolic strain rate and exercise capacity in mild heart failure with preserved ejection fraction: a cardiovascular magnetic resonance study
10.1186/s12968-018-0511-6 · doi-reference
Energetic basis for exercise-induced pulmonary congestion in heart failure with preserved ejection fraction
10.1161/circulationaha.121.054858 · doi-reference
Cardiac energetics in patients with chronic heart failure and iron deficiency: an in-vivo (31) P magnetic resonance spectroscopy study
10.1002/ejhf.2454 · doi-reference
Noninvasive measurements of cardiac high-energy phosphate metabolites in dilated cardiomyopathy by using 31P spectroscopic chemical shift imaging
10.1007/s00330-004-2504-0 · doi-reference
Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy
10.1161/01.cir.96.7.2190 · doi-reference
Contributions of 31P-magnetic resonance spectroscopy to the understanding of dilated heart muscle disease
10.1093/eurheartj/16.suppl_o.115 · doi-reference
The creatine kinase system in normal and diseased human myocardium
10.1056/nejm198510243131704 · doi-reference
Metabolic rates of ATP transfer through creatine kinase (CK Flux) predict clinical heart failure events and death
10.1126/scitranslmed.3007328 · doi-reference
Very-low-calorie diet increases myocardial triglyceride content and decreases diastolic left ventricular function in type 2 diabetes with cardiac complications
10.2337/dc13-1423 · doi-reference
Cardiomyocyte triglyceride accumulation and reduced ventricular function in mice with obesity reflect increased long chain fatty acid uptake and de novo fatty acid synthesis
10.1155/2012/205648 · doi-reference
Intravenous lipid infusion results in myocardial lipid droplet accumulation combined with reduced myocardial performance in heparinized rabbits
10.1111/j.1748-1716.1995.tb09847.x · doi-reference
Very low calorie diets are associated with transient ventricular impairment before reversal of diastolic dysfunction in obesity
10.1038/s41366-018-0263-2 · doi-reference
Evidence of a direct effect of myocardial steatosis on LV hypertrophy and diastolic dysfunction in adult and adolescent obesity
10.1016/j.jcmg.2014.12.019 · doi-reference
Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart
10.1096/fj.04-2263com · doi-reference
Empagliflozin treatment is associated with improvements in cardiac energetics and function and reductions in myocardial cellular volume in patients with type 2 diabetes
10.2337/db21-0270 · doi-reference
Effects of weight loss on myocardial energetics and diastolic function in obesity
10.1007/s10554-012-0174-6 · doi-reference
Myocardial energetics in obesity: enhanced ATP delivery through creatine kinase with blunted stress response
10.1161/circulationaha.119.042770 · doi-reference
Reply: ectopic fat deposition and diabetes mellitus
10.1016/j.jacc.2016.09.939 · doi-reference
Relationship between left ventricular structural and metabolic remodeling in type 2 diabetes
10.2337/db15-0627 · doi-reference
Cardiac adaptations to acute hemodynamic stress in function, perfusion, and energetics in Type 2 diabetes with overweight and obesity
10.2337/dc22-0887 · doi-reference
Effects of catecholamine stress on diastolic function and myocardial energetics in obesity
10.1161/circulationaha.111.069518 · doi-reference
Myocardial steatosis and left ventricular contractile dysfunction in patients with severe aortic stenosis
10.1161/circimaging.113.000559 · doi-reference
Role of cardiac energetics in aortic stenosis disease progression: identifying the high-risk metabolic phenotype
10.1161/circimaging.122.014863 · doi-reference
Association between type 2 diabetes and changes in myocardial structure, contractile function, energetics, and blood flow before and after aortic valve replacement in patients with severe aortic stenosis
10.1161/circulationaha.122.063444 · doi-reference